Gerullis H - Search Results

1

N-acetyltransferase 1*10 genotype in bladder cancer patients.

Höhne S, Gerullis H, Blaszkewicz M, Selinski S, Hengstler JG, Otto T, Golka K. Höhne S, et al. Among authors: gerullis h. J Toxicol Environ Health A. 2017;80(7-8):417-422. doi: 10.1080/10937404.2017.1304727. Epub 2017 Jul 11. J Toxicol Environ Health A. 2017. PMID: 28696911

2

Successful transureteropyelostomy after heminephrectomy of a bilateral hydronephrotic horseshoe kidney: a case report.

Gerullis H, Eimer C, Betz D, Otto T. Gerullis H, et al. J Med Case Rep. 2008 Jul 16;2:231. doi: 10.1186/1752-1947-2-231. J Med Case Rep. 2008. PMID: 18631399 Free PMC article.

3

Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany.

Gerullis H, Bergmann L, Maute L, Eimer C, Otto T. Gerullis H, et al. Cancer Chemother Pharmacol. 2009 May;63(6):1097-102. doi: 10.1007/s00280-008-0835-2. Epub 2008 Sep 26. Cancer Chemother Pharmacol. 2009. PMID: 18818922

4

Temsirolimus in renal cell carcinoma.

Otto T, Eimer C, Gerullis H. Otto T, et al. Among authors: gerullis h. Transplant Proc. 2008 Dec;40(10 Suppl):S36-9. doi: 10.1016/j.transproceed.2008.10.006. Transplant Proc. 2008. PMID: 19100905

5

Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma.

Gerullis H, Bergmann L, Maute L, Ecke TH, Eimer C, Bagner JW, Otto T. Gerullis H, et al. Med Oncol. 2010 Jun;27(2):373-8. doi: 10.1007/s12032-009-9220-1. Epub 2009 Apr 28. Med Oncol. 2010. PMID: 19399651

6

Re: White et al.: Comparative analysis of surgical margins between radical retropubic prostatectomy and RALP: Are patients sacrificed during initiation of robotic program? (Urology 2009;73:567-571).

Otto T, Gerullis H, Theuerkauf I. Otto T, et al. Among authors: gerullis h. Urology. 2009 Aug;74(2):475-6; author reply 476. doi: 10.1016/j.urology.2009.04.031. Urology. 2009. PMID: 19646635 No abstract available.

7

Nephrocutaneous bypass in ureteral obstruction.

Gerullis H, Ecke TH, Schwartmann K, Heuck CJ, Eimer C, Bagner JW, Kocheril S, Otto T. Gerullis H, et al. Urology. 2010 Aug;76(2):480-5. doi: 10.1016/j.urology.2009.10.076. Epub 2010 Feb 13. Urology. 2010. PMID: 20156649

8

mTOR-inhibition in metastatic renal cell carcinoma. Focus on temsirolimus: a review.

Gerullis H, Ecke TH, Eimer C, Heuck CJ, Otto T. Gerullis H, et al. Minerva Urol Nefrol. 2010 Dec;62(4):411-23. Minerva Urol Nefrol. 2010. PMID: 20944541 Review.

9

Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review.

Gerullis H, Ecke T, Eimer C, Wishahi M, Otto T. Gerullis H, et al. Anticancer Drugs. 2011 Jan;22(1):9-17. doi: 10.1097/CAD.0b013e3283404db0. Anticancer Drugs. 2011. PMID: 20948429 Review.

10

mTOR inhibition in advanced renal cell carcinoma: which criteria should be used to evaluate therapeutic outcome?

Eimer C, Gerullis H, Heuck C, Otto T. Eimer C, et al. Among authors: gerullis h. Anticancer Drugs. 2011 Jan;22(1):18-23. doi: 10.1097/CAD.0b013e3283407dde. Anticancer Drugs. 2011. PMID: 21037468 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page